# Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/postapproval-manufacturing-changes-to-biosimilar-and-interchangeable-biosimilar-products-questions-and-answers/f791f37f-3382-48a9-8fcb-f27046ac94a4

> FDA guidance document: Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers. Issue date: July 23, 2024. Get complete insights and analysis.

---

## Details

- Title: Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-07-23
- Comment Close Date: 2024-09-23
- Last Changed: 2024-07-23
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-2581">FDA-2024-D-2581</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Labeling for Biosimilar and Interchangeable Biosimilar Products](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-and-interchangeable-biosimilar-products/54a5f712-03f5-4993-b0d7-6a1c2f261eff)
- [Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products —  Content and Format   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-abuse-and-dependence-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format-guidance-for-industry/e65bdb77-e74c-42d7-aab4-482af24834d1)